0001694665-23-000167.txt : 20231103
0001694665-23-000167.hdr.sgml : 20231103
20231103161113
ACCESSION NUMBER: 0001694665-23-000167
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231101
FILED AS OF DATE: 20231103
DATE AS OF CHANGE: 20231103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Thorell Marella
CENTRAL INDEX KEY: 0001826323
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38473
FILM NUMBER: 231376437
MAIL ADDRESS:
STREET 1: 1226 CHARTER LANE
CITY: AMBLER
STATE: PA
ZIP: 19002
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Evelo Biosciences, Inc.
CENTRAL INDEX KEY: 0001694665
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465594527
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE KENDALL SQUARE, 600/700, SUITE 7-201
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-577-0300
MAIL ADDRESS:
STREET 1: ONE KENDALL SQUARE, 600/700, SUITE 7-201
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
wk-form4_1699042256.xml
FORM 4
X0508
4
2023-11-01
0
0001694665
Evelo Biosciences, Inc.
EVLO
0001826323
Thorell Marella
C/O EVELO BIOSCIENCES, INC.
ONE KENDALL SQUARE, 600/700, SUITE 7-201
CAMBRIDGE
MA
02139
0
1
0
0
Chief Financial Officer
1
Common Stock
2023-11-01
4
M
0
12500
A
21569
D
Common Stock
2023-11-02
4
S
0
3999
0.33
D
17570
D
Restricted Stock Units
2023-11-01
4
M
0
12500
0
D
Common Stock
12500
25000
D
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction entered into by the Reporting Person, solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $0.31 to $0.33, inclusive. The Reporting Person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4.
The RSUs vest in three (3) substantially equal installments on each of November 1, 2023, February 1, 2024 and May 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date. These RSUs have no expiration date.
/s/ Marella Thorell
2023-11-03